Account Login
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Denali Therapeutics Inc (NQ: DNLI )

61.04 USD UNCHANGED
Streaming Delayed Price Updated: 6:28 PM EST, Mar 5, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 61.04
Bid (Size) 60.80 (1)
Ask (Size) 62.86 (2)
Prev. Close 61.04
Today's Range 61.04 - 61.04
52wk Range 12.39 - 93.94
Shares Outstanding 94,441,892
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Denali Therapeutics Reports Full Year 2020 Financial Results and Business Highlights
From GlobeNewswire News Releases
Cellarity Raises $123 Million in Series B Funding to Pioneer a New Approach to Drug Discovery, Treating Disease at the Level of the Cell as Opposed to a Single Molecular Target
Cellarity, a life sciences company founded by Flagship Pioneering to develop a new method of drug discovery targeting the cell, announced today that it raised $123 million in Series B financing. The... 
From PR Newswire

Performance

YTD
-13.86%
-13.86%
1 Month
-13.50%
-13.50%
3 Month
-15.26%
-15.26%
6 Month
+100.39%
+100.39%
1 Year
+251.82%
+251.82%

More News

Read More
Denali Therapeutics Reports Positive Three-Month Data from Phase 1/2 Study with ETV:IDS (DNL310) in Patients with Hunter Syndrome (MPS II)
From GlobeNewswire News Releases
Denali Therapeutics to Present New Data on ETV:IDS (DNL310) for the Potential Treatment of Hunter Syndrome at WORLDSymposium™
From GlobeNewswire News Releases
Analysts Predict 18% Upside For The Holdings of PTH
Tags ETFs
From ETF Channel
Denali Therapeutics Announces Appointment of Nancy Thornberry to Board of Directors
From GlobeNewswire News Releases
Denali Therapeutics Announces Significant Program Progress and Expected Key Milestones in 2021 for Its Broad Therapeutic Portfolio in Neurodegeneration
From GlobeNewswire News Releases
10 Biggest Price Target Changes For Friday
Tags DNLI TWTR DPZ
From Benzinga
10 Health Care Stocks Showing Unusual Options Activity In Today's Session
Tags Market News MRKR Benzinga
From Benzinga
Lilly Strikes Licensing Deal With Rigel In Push Toward Neurological, Immunological Therapies
Tags DNLI Movers Biotech
From Benzinga
Denali's Enzyme Replacement Therapy Shows Encouraging Biomarker Effects In Early-Stage Hunter Syndrome Study
Tags FDA DNLI Market News
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.